Efficacy and safety of a decision rule for using antibiotics in children with pneumonia and vaccinated against

Fernando Ferrero1, Fernando Adrián Torres2, Paula Domínguez3

  • 1Departamento de Medicina, Hospital General de Niños Pedro de Elizalde.

Insights

The Bacterial Pneumonia Score (BPS) effectively reduced antibiotic use in vaccinated children with pneumonia. This clinical decision rule identified children needing antibiotics without worsening their outcomes.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Clinical Decision Making

Background:

  • Most childhood pneumonia cases are viral, yet antibiotics are often prescribed.
  • The Bacterial Pneumonia Score (BPS) aids antibiotic decisions but needs evaluation in pneumococcal-vaccinated children.

Purpose of the Study:

  • To assess if the BPS can decrease antibiotic use in vaccinated children with community-acquired pneumonia compared to standard care.

Main Methods:

  • A randomized controlled trial compared BPS-guided antibiotic use versus physician discretion in 65 vaccinated children (3-60 months) with pneumonia.
  • Antibiotic administration was based on BPS score >4 in the intervention group.

Main Results:

  • Antibiotic use was significantly lower in the BPS group (9/33) versus the control group (21/32).
  • No significant difference in unfavorable clinical course between the groups was observed.

Conclusions:

  • The BPS is effective in reducing antibiotic prescribing for pneumococcal-vaccinated children with pneumonia.
  • Implementing the BPS does not increase the risk of adverse outcomes in this population.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
111
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
47
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377